A systematic review and meta-analysis of cancer patients affected by a novel coronavirus

202057 citationsReviewgreen Open Access

Authors

Bhanu Prasad Venkatesulu · Henry Ford Hospital

Viveksandeep Thoguluva Chandrasekar · University of Kansas Medical Center

Prashanth Giridhar

Pragati Advani · National Institutes of Health

Amrish Sharma · The University of Texas MD Anderson Cancer Center

Cheng En Hsieh · The University of Texas MD Anderson Cancer Center

Thiraviyam Elumalai · The Christie NHS Foundation Trust

Abstract

Cancer patients with COVID-19 disease are at increased risk of mortality and morbidity. A more nuanced understanding of the interaction between cancer-directed therapies and COVID-19-directed therapies is needed. This will require uniform prospective recording of data, possibly in multi-institutional registry databases.

Topics & Keywords

COVID-19 and healthcare impacts COVID-19 Clinical Research Studies Healthcare cost, quality, practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: medRxiv

DOI: 10.1101/2020.05.27.20115303